These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 9586583)

  • 41. Detection of cannabinoid receptors by photoaffinity labelling.
    Burstein SH; Audette CA; Charalambous A; Doyle SA; Guo Y; Hunter SA; Makriyannis A
    Biochem Biophys Res Commun; 1991 Apr; 176(1):492-7. PubMed ID: 1850270
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Binding of the non-classical cannabinoid CP 55,940, and the diarylpyrazole AM251 to rodent brain cannabinoid receptors.
    Gatley SJ; Lan R; Pyatt B; Gifford AN; Volkow ND; Makriyannis A
    Life Sci; 1997; 61(14):PL 191-7. PubMed ID: 9335234
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effects of delta9-tetrahydrocannabinol physical dependence on brain cannabinoid receptors.
    Breivogel CS; Scates SM; Beletskaya IO; Lowery OB; Aceto MD; Martin BR
    Eur J Pharmacol; 2003 Jan; 459(2-3):139-50. PubMed ID: 12524139
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain.
    Sugiura T; Kondo S; Sukagawa A; Nakane S; Shinoda A; Itoh K; Yamashita A; Waku K
    Biochem Biophys Res Commun; 1995 Oct; 215(1):89-97. PubMed ID: 7575630
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Time course of the effects of different cannabimimetics on prolactin and gonadotrophin secretion: evidence for the presence of CB1 receptors in hypothalamic structures and their involvement in the effects of cannabimimetics.
    Fernández-Ruiz JJ; Muñoz RM; Romero J; Villanua MA; Makriyannis A; Ramos JA
    Biochem Pharmacol; 1997 Jun; 53(12):1919-27. PubMed ID: 9256167
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Delta9-tetrahydrocannabinol, but not the endogenous cannabinoid receptor ligand anandamide, produces conditioned place avoidance.
    Mallet PE; Beninger RJ
    Life Sci; 1998; 62(26):2431-9. PubMed ID: 9651110
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cannabinoid interactions with glucocorticoid receptors in rat hippocampus.
    Eldridge JC; Landfield PW
    Brain Res; 1990 Nov; 534(1-2):135-41. PubMed ID: 1963558
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification and characterization of a novel synthetic cannabinoid CP 55,940 binder in rat brain cytosol.
    Qureshi J; Saady M; Cardounel A; Kalimi M
    Mol Cell Biochem; 1998 Apr; 181(1-2):21-7. PubMed ID: 9562238
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Stereospecific and regioselective hydrolysis of cannabinoid esters by ES46.5K, an esterase from mouse hepatic microsomes, and its differences from carboxylesterases of rabbit and porcine liver.
    Watanabe K; Matsunaga T; Kimura T; Funahashi T; Yamaori S; Shoyama Y; Yamamoto I
    Biol Pharm Bull; 2005 Sep; 28(9):1743-7. PubMed ID: 16141551
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The search for selective ligands for the CB2 receptor.
    Huffman JW
    Curr Pharm Des; 2000 Sep; 6(13):1323-37. PubMed ID: 10903395
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of two cloned human CB1 cannabinoid receptor isoforms.
    Rinaldi-Carmona M; Calandra B; Shire D; Bouaboula M; Oustric D; Barth F; Casellas P; Ferrara P; Le Fur G
    J Pharmacol Exp Ther; 1996 Aug; 278(2):871-8. PubMed ID: 8768742
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization and distribution of binding sites for [3H]-SR 141716A, a selective brain (CB1) cannabinoid receptor antagonist, in rodent brain.
    Rinaldi-Carmona M; Pialot F; Congy C; Redon E; Barth F; Bachy A; Brelière JC; Soubrié P; Le Fur G
    Life Sci; 1996; 58(15):1239-47. PubMed ID: 8614277
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Sex difference in the oxidative metabolism of delta 9-tetrahydrocannabinol in the rat.
    Narimatsu S; Watanabe K; Yamamoto I; Yoshimura H
    Biochem Pharmacol; 1991 Apr; 41(8):1187-94. PubMed ID: 1848985
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Involvement of mu-, delta- and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats.
    Solinas M; Goldberg SR
    Psychopharmacology (Berl); 2005 Jun; 179(4):804-12. PubMed ID: 15619107
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phospholipase participation in cannabinoid-induced release of free arachidonic acid.
    Burstein S; Budrow J; Debatis M; Hunter SA; Subramanian A
    Biochem Pharmacol; 1994 Sep; 48(6):1253-64. PubMed ID: 7945419
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Cannabinoid ligand-receptor signaling in the mouse uterus.
    Das SK; Paria BC; Chakraborty I; Dey SK
    Proc Natl Acad Sci U S A; 1995 May; 92(10):4332-6. PubMed ID: 7753807
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mechanism of hepatic microsomal oxidation of 11-hydroxy-delta 8-tetrahydrocannabinol to 11-oxo-delta 8-tetrahydrocannabinol. Evidence for hydration of the aldehyde formed.
    Watanabe K; Matsunaga T; Narimatsu S; Yamamoto I; Yoshimura H
    J Pharmacobiodyn; 1992 Jun; 15(6):311-7. PubMed ID: 1331394
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antitumor effects of ajulemic acid (CT3), a synthetic non-psychoactive cannabinoid.
    Recht LD; Salmonsen R; Rosetti R; Jang T; Pipia G; Kubiatowski T; Karim P; Ross AH; Zurier R; Litofsky NS; Burstein S
    Biochem Pharmacol; 2001 Sep; 62(6):755-63. PubMed ID: 11551521
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Urinary excretion profiles of 11-nor-9-carboxy-delta9-tetrahydrocannabinol and 11-hydroxy-delta9-THC: cannabinoid metabolites to creatinine ratio study IV.
    Fraser AD; Worth D
    Forensic Sci Int; 2004 Jul; 143(2-3):147-52. PubMed ID: 15240035
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Catalytic activity of cytochrome P450 isozymes purified from rat liver in converting 11-oxo-delta 8-tetrahydrocannabinol to delta 8-tetrahydrocannabinol-11-oic acid.
    Watanabe K; Matsunaga T; Narimatsu S; Yamamoto I; Imaoka S; Funae Y; Yoshimura H
    Biochem Pharmacol; 1991 Aug; 42(6):1255-9. PubMed ID: 1653566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.